Exanthema Market - Forecast(2019 - 2024)

Report Code: HCR 0207 Report Format: PDF + Excel (Delivery in 48 Hrs)
Viral exanthema refers to widespread skin rash followed by high fever, observed in infants and caused due to viral infection. Rashes usually occur on arms, legs and trunk in the form of pink to red spots. These rashes may or may not be itchy in nature and sometimes the patient may suffer from fever, fatigue, loss of appetite, pains, headache and irritability. Treatment is required in cases of severe symptoms such as diarrhea, vomiting, severe abdominal pain, seizures, stiff neck, red eyes and sputum with pus or blood. However, certain medications can be taken for low fever, headaches and pains and others. Globally, increasing research activities for development of novel therapeutics against viral exanthema symptoms, rise in susceptibility of infants towards these infections due to weak immune system and increasing government support are the prime growth drivers of exanthema market. In addition, increase in cases of exanthema in emerging economies such as China, India, Brazil and others, will create new opportunities for exanthema market. However, higher cost of the research, negligence towards diagnosing the symptoms and lack of standardization are the key restraints for exanthema market.

This report identifies the global exanthema market size in for the year 2014-2016 and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects with respect to global exanthema market.
Exanthema Market

Geographically, North America dominated the exanthema market and Asia Pacific is projected to have fastest growth, owing to rapidly increasing awareness levels, modernizing healthcare infrastructure and favourable government support in this region. Chloroamphenicol sodium succinate, tazarotene and threolone are some of the drugs in the investigational phases for treatment of exanthema.

This report segments exanthema market on the basis of type and regional market as follows:
  • Exanthema Market, By Product: Rubeola, Rubella, Erythema Infectiosum and Roseola Infantum
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region

Sample Companies Profiled in this Report are:
  • Manus Aktteva Biopharma LLP
  • Teva Pharmaceutical Industries Ltd.
  • CIRON Drugs & Pharmaceuticals Pvt. Ltd.
  • Iol Chemicals And Pharmaceuticals Limited
  • Reckitt Benckiser Group plc
  • 10+
1. Exanthema Market –Overview
2. Executive Summary
3. 
Exanthema Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Exanthema Market–Forces
   4.1. Drivers
      4.1.1. Increasing research activities for development of novel therapeutics against viral exanthema symptoms
      4.1.2. Rise in susceptibility of infants towards these infections due to weak immune system
      4.1.3. Increasing government support
   4.2. Restraints
      4.2.1. The research and development having higher cost
      4.2.2. Lack of standardization
      4.2.3. Negligence towards diagnosing the symptoms
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Exanthema Market, By Type
   5.1. Rubeola
   5.2. Rubella
   5.3. Erythema Infectiosum
   5.4. Roseola Infantum
6. Exanthema Market, By Geography
   6.1. Europe
      6.1.1. Germany
      6.1.2. France
      6.1.3. Italy
      6.1.4. Spain
      6.1.5. Russia
      6.1.6. U.K.
      6.1.7. Rest of Europe
   6.2. Asia Pacific
      6.2.1. China
      6.2.2. India
      6.2.3. Japan
      6.2.4. South Korea
      6.2.5. Rest of Asia-Pacific
   6.3. North America
      6.3.1. U.S.
      6.3.2. Canada
      6.3.3. Mexico
   6.4. Rest of the World (RoW)
      6.4.1. Brazil
      6.4.2. Rest of RoW
7. Exanthema – Market Entropy
   7.1. Expansion
   7.2. Technological Developments
   7.3. Merger & Acquisitions and Joint Ventures
   7.4. Supply- Contract
8. Company Profiles(By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   8.1. Manus Aktteva Biopharma LLP
   8.2. Teva Pharmaceutical Industries Ltd.
   8.3. CIRON Drugs & Pharmaceuticals Pvt. Ltd.
   8.4. Iol Chemicals And Pharmaceuticals Limited
   8.5. Reckitt Benckiser Group plc
   8.6. Mikart Inc
   8.7. Ranbaxy Laboratories Limited
   8.8. West-Ward Pharmaceutical Corp.
   8.9. Nexgen Pharma, Inc
   8.10. Concord Laboratories
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
9. Appendix
   9.1. Abbreviations
   9.2. Sources
   9.3. Research Methodology
   9.4. Bibliography
   9.5. Compilation of Expert Insights
   9.6. Disclaimer
List of Tables:

Table 1: Exanthema Market Overview 2019-2024
Table 2: Exanthema Market Leader Analysis 2018-2019 (US$)
Table 3: Exanthema Market Product Analysis 2018-2019 (US$)
Table 4: Exanthema Market End User Analysis 2018-2019 (US$)
Table 5: Exanthema Market Patent Analysis 2013-2018* (US$)
Table 6: Exanthema Market Financial Analysis 2018-2019 (US$)
Table 7: Exanthema Market Driver Analysis 2018-2019 (US$)
Table 8: Exanthema Market Challenges Analysis 2018-2019 (US$)
Table 9: Exanthema Market Constraint Analysis 2018-2019 (US$)
Table 10: Exanthema Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Exanthema Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Exanthema Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Exanthema Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Exanthema Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Exanthema Market Value Chain Analysis 2018-2019 (US$)
Table 16: Exanthema Market Pricing Analysis 2019-2024 (US$)
Table 17: Exanthema Market Opportunities Analysis 2019-2024 (US$)
Table 18: Exanthema Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Exanthema Market Supplier Analysis 2018-2019 (US$)
Table 20: Exanthema Market Distributor Analysis 2018-2019 (US$)
Table 21: Exanthema Market Trend Analysis 2018-2019 (US$)
Table 22: Exanthema Market Size 2018 (US$)
Table 23: Exanthema Market Forecast Analysis 2019-2024 (US$)
Table 24: Exanthema Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Exanthema Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: Exanthema Market By Type, Revenue & Volume, By Rubeola, 2019-2024 ($)
Table 27: Exanthema Market By Type, Revenue & Volume, By Rubella, 2019-2024 ($)
Table 28: Exanthema Market By Type, Revenue & Volume, By Erythema Infectiosum, 2019-2024 ($)
Table 29: Exanthema Market By Type, Revenue & Volume, By Roseola Infantum, 2019-2024 ($)
Table 30: North America Exanthema Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 31: South america Exanthema Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 32: Europe Exanthema Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 33: APAC Exanthema Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 34: Middle East & Africa Exanthema Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 35: Russia Exanthema Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 36: Israel Exanthema Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 37: Top Companies 2018 (US$) Exanthema Market, Revenue & Volume
Table 38: Product Launch 2018-2019 Exanthema Market, Revenue & Volume
Table 39: Mergers & Acquistions 2018-2019 Exanthema Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Exanthema Market 2019-2024
Figure 2: Market Share Analysis for Exanthema Market 2018 (US$)
Figure 3: Product Comparison in Exanthema Market 2018-2019 (US$)
Figure 4: End User Profile for Exanthema Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Exanthema Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Exanthema Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Exanthema Market 2018-2019
Figure 8: Ecosystem Analysis in Exanthema Market 2018
Figure 9: Average Selling Price in Exanthema Market 2019-2024
Figure 10: Top Opportunites in Exanthema Market 2018-2019
Figure 11: Market Life Cycle Analysis in Exanthema Market
Figure 12: GlobalBy Type Exanthema Market Revenue, 2019-2024 ($)
Figure 13: Global Exanthema Market - By Geography
Figure 14: Global Exanthema Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global Exanthema Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America Exanthema Market Value & Volume, 2019-2024 ($)
Figure 17: US Exanthema Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Exanthema Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Exanthema Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Exanthema Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil Exanthema Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Exanthema Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Exanthema Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Exanthema Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Exanthema Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Exanthema Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Exanthema Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Exanthema Market Value & Volume, 2019-2024 ($)
Figure 59: U.K Exanthema Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Exanthema Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Exanthema Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Exanthema Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Exanthema Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Exanthema Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Exanthema Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Exanthema Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Exanthema Market Value & Volume, 2019-2024 ($)
Figure 92: China Exanthema Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($) Exanthema Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Exanthema Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Exanthema Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Exanthema Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Exanthema Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Exanthema Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Exanthema Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Exanthema Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia Exanthema Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Exanthema Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%) Exanthema Market
Figure 130: Developments, 2018-2019* Exanthema Market
Figure 131: Company 1 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Exanthema Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Exanthema Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Exanthema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Exanthema Market Net Sales Share, By Geography, 2018 (%)